
Blueprint Medicines Corporation BPMC
Quartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation P/S 2011-2026 | BPMC
P/S Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.7 | 21.3 | 13 | 34.8 | 7.71 | 46.2 | 69.9 | 143 | 32.9 | 25.1 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 143 | 7.71 | 40.5 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 97.57 | 2.17 % | $ 27.2 B | ||
|
Aligos Therapeutics
ALGS
|
30.2 | $ 8.49 | 6.25 % | $ 83.9 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.63 | -2.42 % | $ 8.73 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 2.15 | -0.69 % | $ 447 M | ||
|
Evogene Ltd.
EVGN
|
71.3 | $ 0.83 | 2.5 % | $ 27.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 20.87 | 2.45 % | $ 976 M | ||
|
Genmab A/S
GMAB
|
15.6 | $ 28.23 | -0.07 % | $ 18 B | ||
|
Grifols, S.A.
GRFS
|
1.71 | $ 8.24 | 0.3 % | $ 6.83 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Halozyme Therapeutics
HALO
|
6.91 | $ 66.86 | -1.42 % | $ 8.01 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Harmony Biosciences Holdings
HRMY
|
1.85 | $ 28.5 | -1.35 % | $ 1.64 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.42 | $ 1.43 | 2.14 % | $ 368 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 2.91 | -0.26 % | $ 4.79 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.18 | 2.45 % | $ 447 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.96 | -1.03 % | $ 3.05 B | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
1.32 K | $ 32.21 | -0.09 % | $ 2.14 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.49 | -0.34 % | $ 397 M | ||
|
Incyte Corporation
INCY
|
3.79 | $ 94.65 | -1.48 % | $ 18.5 B | ||
|
Cidara Therapeutics
CDTX
|
116 | - | - | $ 1.41 B | ||
|
Innate Pharma S.A.
IPHA
|
14.7 | $ 1.48 | 4.61 % | $ 235 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.57 | 0.78 % | $ 16.1 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | - | - | $ 96.9 B | ||
|
Inventiva S.A.
IVA
|
128 | $ 5.15 | -2.09 % | $ 138 M |